For screening genes in the linked interval, coding exons and their splice sites were amplified from genomic DNA of two affected patients and one unaffected individual. Reference genomic sequences are available from GenBank (accession no. NT_010498). PCR amplification of 13 exons using primers listed in
Table 1 was performed in 20-μL reactions. Exons 1, 2, 3, 4, 5, and 6 were amplified with
Taq polymerase (LATaq; Takara Bio, Inc., Shiga, Japan). Exons 7, 8, 9, 10, 11, 12, and 13, were amplified with 2.5 IU
Taq (
Taq Gold; ABI), 10 × 2 μL buffer (
Taq Gold; ABI), 1.9 mM MgCl
2, 0.25 mM dNTP, 0.25 μM primers, and 100 ng genomic DNA. PCR cycling consisted of an initial 10-minute denaturation step of 95°C for 5minutes; 32 cycles of 94°C for 40 seconds, 55°C for 30 seconds, and 72°C for 30 seconds; and a final elongation step at 72°C for 5 minutes. PCR products were purified with either of two kits (PCR purification kit; Qiagen, Valencia, CA; or a QuickStep2 PCR purification kit; Edge Biosystems, Gaithersburg, MD). The PCR template was sequenced using dye-termination chemistry (Big Dye Terminator, ver. 1; ABI) in a final reaction of 10 μL. Products of the sequencing reactions were purified with a gel-filtration system (Performa DTR System; Edge Biosystem) and run on a gene analyzer (model 3100; ABI). Sequences were aligned on computer (Seqman; DNAStar, Inc., Madison, WI). The same approach was used to sequence exon 12 and the flanking intronic sequences of the
HSF4 gene from DNA from all family members and 175 control individuals including 87 Tunisians, 41 Barbadians, and 47 Indians. DNA from Tunisian individuals was collected from the genetics department at Charles Nicolle Hospital, and the remaining control DNA samples were available through studies performed at the National Eye Institute and collaborating institutions. All subjects gave their consent for anonymous use of their DNA samples.